iBio, Inc. is a NYSE-listed (NYSE MKT: IBIO) leader in plant-based biotechnology which develops and manufactures PMPs and biological products. iBio’s unique plant-based platform has garnered significant interest from manufacturers, scientists, and the public, primarily due to its ability to make proteins quickly and inexpensively. This process represents an industry breakthrough in biologics and uses green plants for the production of biopharmaceuticals such as vaccines, drugs, and monoclonal antibodies.
This process represents an industry breakthrough in biologics and uses green plants for the production of biopharmaceuticals such as vaccines, drugs, and monoclonal antibodies.
This is a subject covered enthusiastically by editors in 2015-2016. McDAY PR pitched a Plant Tour article and won the cover story for the company in Pharmaceutical Manufacturing (Oct 2016) as well as securing an e-book on PMPs in BioPharm International, plus live interviews with Pharmaceutical Technology, Interphex and a stream of blog posts to ISPE and the company’s own website.
Read the article on the Destini Profiler in the INTERPHEX Show Daily April 2016
Gore helps pharmaceutical and biotechnology manufacturers compete in an increasingly regulatory-driven landscape with traceable solutions – both long-term use process components and single-use products – for transferring, storing, filtering, and drug processing.
Sentinel Process Systems
Sentinel Process Systems (www.kilolabs.com) continues to be one of McDAY’s favorite clients, not only because of the energy and experience inside the company but because of the attention to detail for its own pharmaceutical and specialty chemical clients, which mirrors our own.
Sentinel Process Systems, Inc. has over six decades of experience in locating the best suppliers for its customers in the pharmaceutical and specialty chemicals industry. Sentinel is recognized as a high-quality design and build process systems supplier as well as a manufacturer’s representative of specialized equipment for kilo labs and pilot plants.
Kneat Validation Lifecycle Software
Kneat is a powerful software platform for Electronic Validation Life Cycle Management for Pharmaceutical, Biotech, and Medical Device Manufacturers. Kneat can create a paperless environment and centralized best practice Validation process that can be leveraged seamlessly across a company’s multiple global sites. Kneat delivers a quantum increase in efficiency by slashing the cost of Validation Compliance in all areas and across the full lifecycle.
McDAY’s goal was to assist Kneat’s United States market entry. We have worked for twelve months with Kneat on business development in life sciences, helping connect CEO Eddie Ryan with key decision makers in the US in pharma, biotech, and medical devices.
LotusWorks’ Startup, Commissioning and Calibration Services teams have been serving Pharmaceutical clients like Pfizer, Biogen Idec and BMS in the life sciences-rich areas of Ireland and the U.S. since 1999.
McDAY’s connections in the pharmaceutical industry are the underpinning of work with this client. After identifying key pharma targets, email campaigns, personal introductions and guerrilla marketing tactics like direct mail, sales phone scripts were used to meet key decision makers at pharmaceutical trade shows and have resulted in deeper penetration of Lotusworks’ people onto pharmaceutical sites. Our Child’s Play Email Campaign, sent to over 2,000 process and CQV engineers, start-up specialists, and construction professionals, is shown here.
McDAY built and designed a new website for Gradalis, a Phase II start-up company, which is currently in promising Phase III trials for tumor-specific vaccines for ovarian and other cancers. The scientists at Gradalis were involved in every creative design decision, with a personal stake in ensuring that women were represented at every stage of life.
Gradalis’ website showcases a typical sample of our work for early-stage companies with plans to go public.
GetReskilled, an Irish-based video learning company focused on pharmaceutical and medical device training of manufacturing operators and technicians, was opening an office in Boston, MA and needed assistance in expanding their base of business, stateside.
McDAY’s team of public relations experts and technical writers spent time with the GetReskilled CEO, Gerry Creaner, and then, based on those conversations, talked to dozens of editors in the highly technical biopharmaceutical editorial community, writing and placing articles in Controlled Environments, Medical Device Online, Contract Pharma, Pharmaceutical Manufacturing, and the Irish Echo. A partnership with online assessment firm, cut-e, gave rise to a new product, branded by McDAY’s creative team as BPS, Behavioral Positioning System, which helps manufacturing teams “navigate” their way to improved quality performance.
Klyo (means “to hear, to listen” in Greek) is an alliance of seven companies who have come together to transform the way problems are solved in the biopharmaceutical industry. Rockwell Automation, The Beck Group, EEA Consulting Engineers (MEP firm), CBR Int’l (Regulatory), Laurus Bio, McDAY, and Holtz Biopharma Consulting are the seven firms. Dr. Barry Holtz, the founder and former CEO of G-Con, is the visionary behind this alliance, and McDAY is helping to make it a reality.
Since 1974, ABEC has been a leader in delivering integrated process solutions for manufacturing in the biopharmaceutical industry. Their unique value is based on long experience, complete in-house capabilities, a custom, flexible approach, and long-term credibility. ABEC’s turn-key solutions reduce overall cost and time to market while delivering maximum productivity.
McDAY supported ABEC’s strategic marketing initiatives with technical writing, PR, and graphic design.
Learn more about ABEC.
The Brydges Group
Bill Brydges, CEO of the Brydges Group, came to McDay with the concept of using the Brydges name as inspiration for a series of bridges for the company’s new website. McDAY’s design team worked with a variety of bridge images to develop the Brydges Group website. The Brydges Group also works with McDAY on projects inside the biopharmaceutical industry, which are focused on bringing innovative technologies and solutions to high-level executives in little time but with great interest and in seeing cutting edge developments in the industry.
IDEA2.0 is a design review service that can often significantly reduce the total project cost for new and retrofit capital projects by conducting an in-depth peer review of the proposed design at the end of the concept stage. The Director, Geoff Middleton, had come up with the Idea2.0 name, and McDAY helped to brand his concept as a “brilliant and outrageous” new idea inside pharmaceutical engineering and manufacturing.
McDAY designed all marketing materials, including brochure, logo, branding guidelines, and landing page. We immediately classified this idea as “brilliant” because to implement the design suggestions found during an IDEA2.0 review can save a pharmaceutical company millions. We believed it to be “outrageous” as well because Idea2.0 charges nothing to perform the review. And because this approach turns the Master Services Agreement-only mindset of current procurement departments completely on its head, which is exactly what we wanted to drive attention towards in the direction of IDEA2.0.